These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19184231)

  • 1. Predicting prognosis of gastric cancer: limitations of metastatic lymph nodes number and promise of genomics.
    Liakakos T; Karatzas G
    Ann Surg Oncol; 2009 May; 16(5):1432-3; author reply 1434. PubMed ID: 19184231
    [No Abstract]   [Full Text] [Related]  

  • 2. A common misuse of stepwise regression in studies of ratio of metastatic lymph nodes for gastric cancer.
    Wang X; Wan F; Wang JJ
    Ann Surg Oncol; 2008 Jun; 15(6):1805-6. PubMed ID: 18398657
    [No Abstract]   [Full Text] [Related]  

  • 3. The lymph node ratio staging system in gastric cancer.
    Xu DZ
    Ann Surg Oncol; 2010 Feb; 17(2):659. PubMed ID: 19888633
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymph nodes and gastric cancer.
    Coburn NG
    J Surg Oncol; 2009 Mar; 99(4):199-206. PubMed ID: 19142901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of laparoscopic staging on therapy of stomach carcinoma].
    Karpeh MS
    Chirurg; 2002 Apr; 73(4):306-11. PubMed ID: 12063913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of lymph node metastasis classified by the anatomical site or by the number of nodes involved on prognosis of patients with gastric cancer.
    Hidaka H; Eto T; Maehara N; Jimi S; Hotokezaka M; Chijiiwa K
    Hepatogastroenterology; 2008; 55(88):2269-72. PubMed ID: 19260520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new TNM classification and its effect on surgical treatment of stomach cancer].
    Schlag P; Buhl K; Schwarz V; Möller P; Herfarth C
    Chirurg; 1989 Jan; 60(1):8-15. PubMed ID: 2920623
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer.
    Kulig J; Sierzega M; Kolodziejczyk P; Popiela T;
    Br J Surg; 2009 Aug; 96(8):910-8. PubMed ID: 19591164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic usefulness of lymph node ratio in understaged gastric cancer.
    Santiago JR; Osorio J; Gutierrez I; Perez N; Mufioz E; Veloso E; Marco C
    Hepatogastroenterology; 2009; 56(94-95):1557-61. PubMed ID: 19950830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: an analysis based on a Chinese population.
    Wang X; Wan F; Pan J; Yu GZ; Chen Y; Wang JJ
    J Surg Oncol; 2009 May; 99(6):329-34. PubMed ID: 19208438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sinusoidal-follicular hyperplasia of regional lymph nodes in cancer of the stomach and its prognostic significance].
    Bugrov VV; Savinov VA
    Sov Med; 1989; (11):118-9. PubMed ID: 2626703
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes.
    Kim CY; Yang DH
    Ann Surg Oncol; 2009 Jul; 16(7):1868-74. PubMed ID: 19434459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph nodes in gastric cancer.
    Ozmen MM; Ozmen F; Zulfikaroglu B
    J Surg Oncol; 2008 Nov; 98(6):476-81. PubMed ID: 18720367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
    Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current therapy for stomach cancer].
    Sendler A; Siewert JR
    Dtsch Med Wochenschr; 2000 Mar; 125(12):359-62. PubMed ID: 10767873
    [No Abstract]   [Full Text] [Related]  

  • 17. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
    Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
    Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of the invasion of the gastric wall and regional lymph nodes in the prognosis of stomach carcinoma].
    Vitale M; Coda A; Massa G; Comoglio S
    Minerva Chir; 1988 Apr; 43(8):677-81. PubMed ID: 3173736
    [No Abstract]   [Full Text] [Related]  

  • 19. Tailoring treatments for curable gastric cancer.
    Sano T
    Br J Surg; 2007 Mar; 94(3):263-4. PubMed ID: 17318802
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.